Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Pea

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Pathology|July 30, 2025
The importance of tumor microenvironment modulations in the progression of pancreatic intraductal papillary mucinous neoplasms<sup>†</sup>Antonio Pea, Claudio Luchini
Annals of Surgical Oncology|June 22, 2026
ASO Author Reflections: When is Surgery "Too Late" in IPMN Surveillance?Antonio Pea, Roberto Salvia
British Journal of Cancer|November 27, 2021
Artificial intelligence in oncology: current applications and future perspectivesClaudio Luchini, Antonio Pea, Aldo Scarpa
Hepatology (Baltimore, Md.)|March 12, 2020
Biology and Clinical Application of Regulatory RNAs in Hepatocellular CarcinomaAntonio Pea, Nigel B Jamieson, Chiara Braconi
Expert Review of Gastroenterology & Hepatology|September 29, 2015
Genetics of pancreatic neuroendocrine tumors: implications for the clinicAntonio Pea, Ralph H Hruban, Laura D Wood
Chinese Clinical Oncology|May 10, 2019
Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN)Elisabetta Sereni, Claudio Luchini, Roberto Salvia, et al.
Frontiers in Medicine|August 28, 2020
Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine TumorsAlessandra Pulvirenti, Antonio Pea, David K Chang, et al.
Journal of Clinical Medicine|January 7, 2021
Molecular Subtyping and Precision Medicine for Pancreatic CancerFieke E M Froeling, Raffaella Casolino, Antonio Pea, et al.
Frontiers in Medicine|August 28, 2020
Role of Pre-operative Inflammatory Markers as Predictors of Lymph Node Positivity and Disease Recurrence in Well-Differentiated Pancreatic Neuroendocrine Tumours: Pancreas2000 Research and Educational Program (Course 9)Lulu Tanno, Antonio Pea, Taina Nykänen, et al.
Frontiers in Medicine|October 5, 2020
Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study ProtocolAntonio Pea, Lulu Tanno, Taina Nykänen, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Pathology|July 30, 2025
The importance of tumor microenvironment modulations in the progression of pancreatic intraductal papillary mucinous neoplasms<sup>†</sup>Antonio Pea, Claudio Luchini
Annals of Surgical Oncology|June 22, 2026
ASO Author Reflections: When is Surgery "Too Late" in IPMN Surveillance?Antonio Pea, Roberto Salvia
British Journal of Cancer|November 27, 2021
Artificial intelligence in oncology: current applications and future perspectivesClaudio Luchini, Antonio Pea, Aldo Scarpa
Hepatology (Baltimore, Md.)|March 12, 2020
Biology and Clinical Application of Regulatory RNAs in Hepatocellular CarcinomaAntonio Pea, Nigel B Jamieson, Chiara Braconi
Expert Review of Gastroenterology & Hepatology|September 29, 2015
Genetics of pancreatic neuroendocrine tumors: implications for the clinicAntonio Pea, Ralph H Hruban, Laura D Wood
Chinese Clinical Oncology|May 10, 2019
Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN)Elisabetta Sereni, Claudio Luchini, Roberto Salvia, et al.
Frontiers in Medicine|August 28, 2020
Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine TumorsAlessandra Pulvirenti, Antonio Pea, David K Chang, et al.
Journal of Clinical Medicine|January 7, 2021
Molecular Subtyping and Precision Medicine for Pancreatic CancerFieke E M Froeling, Raffaella Casolino, Antonio Pea, et al.
Frontiers in Medicine|August 28, 2020
Role of Pre-operative Inflammatory Markers as Predictors of Lymph Node Positivity and Disease Recurrence in Well-Differentiated Pancreatic Neuroendocrine Tumours: Pancreas2000 Research and Educational Program (Course 9)Lulu Tanno, Antonio Pea, Taina Nykänen, et al.
Frontiers in Medicine|October 5, 2020
Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study ProtocolAntonio Pea, Lulu Tanno, Taina Nykänen, et al.
Pageof 10